Skip to main content
Premium Trial:

Request an Annual Quote

DNA Claims to Baronetcy

Genetic evidence and a judicial committee have come down in favor of Murray Pringle's claim to a Scottish baronetcy, the Guardian reports.

The dispute between Murray Pringle and Simon Robert Pringle, the son of the 10th baronet, over the baronetcy of Stichill arose after DNA was collected from the 10th baronet that indicated that he was not actually part of the male Pringle line.

Instead, it's been suggested that the 8th baronet was not the father of the 9th baronet. Because of this break in the line of paternity, Murray Pringle has argued that he is the rightful heir as he is descended from the second son of the 8th baronet.

The baronetcy of Stichill was granted to Robert Pringle and the "male heirs from his body" in 1683, and as the Guardian notes, heirs to a baronetcy must provide evidence of their relationship to the deceased baronet.

This disputed claim between Murray Pringle and Simon Robert Pringle was referred to the judicial committee of the privy council. It found that the DNA evidence indicated to "a high degree of probability" that the 9th baronet was not the son of the 8th baronet, bolstering Murray Pringle's claim to the baronetcy. The committee also says there as no legal ground for excluding such genetic evidence.

The committee notes that the use of genetic evidence in inheritance disputes could have a number of ramifications, the Guardian reports. "DNA evidence [can] reopen a family succession many generations into the past," the committee writes. "Whether this is a good thing and whether legal measures are needed to protect property transactions in the past, the rights of the perceived beneficiary of a trust of property, and the long established expectations of a family, are questions for others to consider."

The Scan

Polygenic Risk Score to Predict Preeclampsia, Gestational Hypertension in Pregnant Women

Researchers in Nature Medicine provide new mechanistic insights into the development of hypertensive disorders of pregnancy, which may help develop therapeutics.

New Oral Nanomedicine Strategy Targets Gut-Brain Axis to Treat IBD

A new paper in Science Advances describes a platform to design polyphenol-armored oral medicines that are effective at treating inflammatory bowel disease.

Phylogenetic Data Enables New Floristic Map

Researchers in Nature Communications use angiosperm phylogenetic data to refine the floristic regions of the world.

Machine Learning Helps ID Molecular Mechanisms of Pancreatic Islet Beta Cell Subtypes in Type 2 Diabetes

The approach helps overcome limitations of previous studies that had investigated the molecular mechanisms of pancreatic islet beta cells, the authors write in their Nature Genetics paper.